Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local NPH insulin injection for split-thickness skin graft donor-site wound healing
IRCT20111118008122N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of insulin isophane in wound (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Size of epithelialized area. Started Jun 2019; status: completed.
02
Drugs
insulin isophane
03
Conditions
wound
Beyond the preview
Go deeper on IRCT20111118008122N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111118008122N2.